메뉴 건너뛰기




Volumn 16, Issue 13, 2002, Pages 1767-1773

Early and late effects of highly active antiretroviral therapy: A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients

Author keywords

Cytokines; HAART; HIV; IL 7; Immunology; Virology

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 160; INTERLEUKIN 2; INTERLEUKIN 7;

EID: 18644382965     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200209060-00009     Document Type: Article
Times cited : (17)

References (43)
  • 1
    • 0034623019 scopus 로고    scopus 로고
    • Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
    • Plana M, Garcia F, Gallart T, et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000, 14:1921-33.
    • (2000) AIDS , vol.14 , pp. 1921-1933
    • Plana, M.1    Garcia, F.2    Gallart, T.3
  • 2
    • 0030052964 scopus 로고    scopus 로고
    • Alterations of the immune response of HIV-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
    • Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations of the immune response of HIV-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 1996, 173:321-329.
    • (1996) J Infect Dis , vol.173 , pp. 321-329
    • Kelleher, A.D.1    Carr, A.2    Zaunders, J.3    Cooper, D.A.4
  • 3
    • 0030868897 scopus 로고    scopus 로고
    • Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
    • Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
    • (1997) Science , vol.277 , pp. 112-116
    • Autran, B.1    Carcelain, G.2    Li, T.S.3
  • 4
    • 17344369291 scopus 로고    scopus 로고
    • Improvement in cell-mediated immune function, during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
    • Angel JB, Kumar A, Parato K, et al. Improvement in cell-mediated immune function, during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 1998, 177:808-904.
    • (1998) J Infect Dis , vol.177 , pp. 808-904
    • Angel, J.B.1    Kumar, A.2    Parato, K.3
  • 5
    • 0032490305 scopus 로고    scopus 로고
    • Long-lasting recovery in CD4 T cell function and viral load reduction after HAART in advanced HIV-1 disease
    • Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T cell function and viral load reduction after HAART in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
    • (1998) Lancet , vol.351 , pp. 1682-1686
    • Li, T.S.1    Tubiana, R.2    Katlama, C.3    Calvez, V.4    Ait Mohand, H.5    Autran, B.6
  • 6
    • 17344365057 scopus 로고    scopus 로고
    • Immunologic responses associated with 12 weeks of combination therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS clinical trial group protocol 315
    • Lederman MM, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS clinical trial group protocol 315. J Infect Dis 1998, 178:70-79.
    • (1998) J Infect Dis , vol.178 , pp. 70-79
    • Lederman, M.M.1    Connick, E.2    Landay, A.3
  • 7
    • 0034119250 scopus 로고    scopus 로고
    • Long-term immunological response in HIV-1 infected subjects receiving potent antiretroviral therapy
    • Kaufmann GR, Bloch M, Zaunders JJ, et al. Long-term immunological response in HIV-1 infected subjects receiving potent antiretroviral therapy. AIDS 2000, 14:959-969.
    • (2000) AIDS , vol.14 , pp. 959-969
    • Kaufmann, G.R.1    Bloch, M.2    Zaunders, J.J.3
  • 8
    • 0033051593 scopus 로고    scopus 로고
    • Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
    • Pontesilli O, Kerkhof-Garde S, Notermans DW, et al. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy. J Infect Dis 1999, 180:76-86.
    • (1999) J Infect Dis , vol.180 , pp. 76-86
    • Pontesilli, O.1    Kerkhof-Garde, S.2    Notermans, D.W.3
  • 9
    • 0002349021 scopus 로고
    • Longitudinal studies of HIV gag-specific cytotoxic T lymphocyte responses over time in several patients
    • Racz P, Letvin NL, Gluckman JC (editors). Basel: Karger
    • Gotch FM, Rowland-Jones S, Nixon DF. Longitudinal studies of HIV gag-specific cytotoxic T lymphocyte responses over time in several patients. In: Cytotoxic T cells in HIV infection. Racz P, Letvin NL, Gluckman JC (editors). Basel: Karger; 1992. pp. 60-72.
    • (1992) Cytotoxic T cells in HIV infection , pp. 60-72
    • Gotch, F.M.1    Rowland-Jones, S.2    Nixon, D.F.3
  • 10
    • 0028236515 scopus 로고
    • Long-term asymptomatic HIV-1 infection with normal and low CD4 counts
    • Keet IPM, Krol A, Klein MR, et al. Long-term asymptomatic HIV-1 infection with normal and low CD4 counts. J Infect Dis 1994, 169:1236-1241.
    • (1994) J Infect Dis , vol.169 , pp. 1236-1241
    • Keet, I.P.M.1    Krol, A.2    Klein, M.R.3
  • 11
    • 0028978720 scopus 로고
    • Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
    • Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retrovir 1995, 11:903-907.
    • (1995) AIDS Res Hum Retrovir , vol.11 , pp. 903-907
    • Riviere, Y.1    McChesney, M.B.2    Porrot, F.3
  • 12
    • 8944257611 scopus 로고    scopus 로고
    • Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection
    • Clerici M, Balotta C, Trabattoni D, et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996; 88:574-579.
    • (1996) Blood , vol.88 , pp. 574-579
    • Clerici, M.1    Balotta, C.2    Trabattoni, D.3
  • 13
    • 0030665257 scopus 로고    scopus 로고
    • Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
    • Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997, 278:147-150.
    • (1997) Science , vol.278 , pp. 147-150
    • Rosenberg, E.S.1    Billingsley, J.M.2    Caliendo, A.M.3
  • 14
    • 0033999127 scopus 로고    scopus 로고
    • Different immunologic profiles characterize HIV infection in HAART-treated and antiretroviral-naive patients with undetectable viremia
    • Clerici M, Seminari E, Suter F, et al. Different immunologic profiles characterize HIV infection in HAART-treated and antiretroviral-naive patients with undetectable viremia. AIDS 2000, 4:109-116.
    • (2000) AIDS , vol.4 , pp. 109-116
    • Clerici, M.1    Seminari, E.2    Suter, F.3
  • 15
    • 0030768593 scopus 로고    scopus 로고
    • Overshoot of HIV-1 viremia after discontinuation of antiretroviral treatment
    • de Jong M, de Boer RN, de Wolf F, et al. Overshoot of HIV-1 viremia after discontinuation of antiretroviral treatment. AIDS 1997, 1:F79-F84.
    • (1997) AIDS , vol.1
    • De Jong, M.1    De Boer, R.N.2    De Wolf, F.3
  • 16
    • 0032581589 scopus 로고    scopus 로고
    • Rebound of HIV plasma viremia following prolonged suppression with combination therapy
    • Montaner JSG, Harris M, Mo T, Harrigan PR. Rebound of HIV plasma viremia following prolonged suppression with combination therapy. AIDS 1998, 12:1398-1399.
    • (1998) AIDS , vol.12 , pp. 1398-1399
    • Montaner, J.S.G.1    Harris, M.2    Mo, T.3    Harrigan, P.R.4
  • 17
    • 0033004630 scopus 로고    scopus 로고
    • Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
    • Harrigan PR, Whaley M, Montaner JSG. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 1999, 13:F59-F62.
    • (1999) AIDS , vol.13
    • Harrigan, P.R.1    Whaley, M.2    Montaner, J.S.G.3
  • 18
    • 0032819454 scopus 로고    scopus 로고
    • Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
    • Garcia F, Plana M, Vidal C, et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 1999, 13:F79-F86.
    • (1999) AIDS , vol.13
    • Garcia, F.1    Plana, M.2    Vidal, C.3
  • 19
    • 0032578854 scopus 로고    scopus 로고
    • A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously naive HIV-1-infected patients
    • Pialoux G, Raffi F, Brun-Vezinet F, et al. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously naive HIV-1-infected patients. N Engl J Med 1998, 339:1269-1276.
    • (1998) N Engl J Med , vol.339 , pp. 1269-1276
    • Pialoux, G.1    Raffi, F.2    Brun-Vezinet, F.3
  • 20
    • 0032578860 scopus 로고    scopus 로고
    • Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
    • Havlir DV, Marschner IC, Hirsch MS, et al. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. N Engl J Med 1998, 339:1261-1268.
    • (1998) N Engl J Med , vol.339 , pp. 1261-1268
    • Havlir, D.V.1    Marschner, I.C.2    Hirsch, M.S.3
  • 21
    • 19244367532 scopus 로고    scopus 로고
    • Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
    • Reijers MH, Weverling GJ, Jurriaans S, et al. Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study. Lancet 1998, 352:185-190.
    • (1998) Lancet , vol.352 , pp. 185-190
    • Reijers, M.H.1    Weverling, G.J.2    Jurriaans, S.3
  • 22
    • 0032547526 scopus 로고    scopus 로고
    • Caution: Should we be treating HIV infection early?
    • Levy JA. Caution: should we be treating HIV infection early? Lancet 1998, 352:982-983.
    • (1998) Lancet , vol.352 , pp. 982-983
    • Levy, J.A.1
  • 23
    • 0032578839 scopus 로고    scopus 로고
    • Therapeutic strategies for HIV infection. Time to think hard
    • Cooper DA. Therapeutic strategies for HIV infection. Time to think hard. N Engl J Med 1998, 339:1297-1299.
    • (1998) N Engl J Med , vol.339 , pp. 1297-1299
    • Cooper, D.A.1
  • 24
    • 0024385934 scopus 로고
    • IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals
    • Clerici M, Stocks NI, Zajac RA, et al. IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 1989, 339:383-386.
    • (1989) Nature , vol.339 , pp. 383-386
    • Clerici, M.1    Stocks, N.I.2    Zajac, R.A.3
  • 25
    • 0035865865 scopus 로고    scopus 로고
    • Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression
    • Angel JB, Parato KG, A Kumar, et al. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. J Infect Dis 2001, 185:546-554.
    • (2001) J Infect Dis , vol.185 , pp. 546-554
    • Angel, J.B.1    Parato, K.G.2    Kumar, A.3
  • 26
    • 0035865868 scopus 로고    scopus 로고
    • Proliferative responses to human immunodeficiency virus type 1 antigens in HIV-1-infected patients with immune reconstitution
    • Blankson JN, Gallant JE, Siliciano RF. Proliferative responses to human immunodeficiency virus type 1 antigens in HIV-1-infected patients with immune reconstitution. J Infect Dis 2001, 183:657-661.
    • (2001) J Infect Dis , vol.183 , pp. 657-661
    • Blankson, J.N.1    Gallant, J.E.2    Siliciano, R.F.3
  • 27
    • 0032499143 scopus 로고    scopus 로고
    • Improvement in CD4+ T cell counts despite persistently detectable HIV viral load
    • Levitz SM. Improvement in CD4+ T cell counts despite persistently detectable HIV viral load. N Engl J Med 1998, 338:1074-1075.
    • (1998) N Engl J Med , vol.338 , pp. 1074-1075
    • Levitz, S.M.1
  • 28
    • 0032492398 scopus 로고    scopus 로고
    • CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
    • Kauffman D. CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet 1998, 351:723-724.
    • (1998) Lancet , vol.351 , pp. 723-724
    • Kauffman, D.1
  • 29
    • 0034943570 scopus 로고    scopus 로고
    • Prevalence and predictive of intermittent viremia with combination HIV therapy
    • Havlir DV, Bassett R, Leviatan R, et al. Prevalence and predictive of intermittent viremia with combination HIV therapy. JAMA 2001, 286:171-179.
    • (2001) JAMA , vol.286 , pp. 171-179
    • Havlir, D.V.1    Bassett, R.2    Leviatan, R.3
  • 30
    • 0032789091 scopus 로고    scopus 로고
    • Levels of HIV-1-specific cytotoxic T lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral theraphy
    • Kalams SA, Goulder PJ, Shea AK, et al. Levels of HIV-1-specific cytotoxic T lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral theraphy. J Virol 1999, 73:6721-6728.
    • (1999) J Virol , vol.73 , pp. 6721-6728
    • Kalams, S.A.1    Goulder, P.J.2    Shea, A.K.3
  • 31
    • 0343183221 scopus 로고    scopus 로고
    • Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency
    • Rinaldo CR Jr, Huang XL, Fan Z, et al. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency. J Virol 2000, 74:4127-4138.
    • (2000) J Virol , vol.74 , pp. 4127-4138
    • Rinaldo C.R., Jr.1    Huang, X.L.2    Fan, Z.3
  • 32
    • 0034623019 scopus 로고    scopus 로고
    • Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
    • Plana M, Garcia F, Gallart T, et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000, 14:1921-1933.
    • (2000) AIDS , vol.14 , pp. 1921-1933
    • Plana, M.1    Garcia, F.2    Gallart, T.3
  • 33
    • 0035282636 scopus 로고    scopus 로고
    • Alterations in T cell phenotype and HIV-1 specific cytotoxicity after potent antiretroviral therapy
    • Seth A, Markee J, Hoering A, et al. Alterations in T cell phenotype and HIV-1 specific cytotoxicity after potent antiretroviral therapy. J Infect Dis 2001, 183:722-729.
    • (2001) J Infect Dis , vol.183 , pp. 722-729
    • Seth, A.1    Markee, J.2    Hoering, A.3
  • 34
    • 0033524838 scopus 로고    scopus 로고
    • Control of viremia in simian immunodeficiency virus infection by CD8+ T lymphocytes
    • Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ T lymphocytes. Science 1999, 283:857-860.
    • (1999) Science , vol.283 , pp. 857-860
    • Schmitz, J.E.1    Kuroda, M.J.2    Santra, S.3
  • 35
    • 0032973455 scopus 로고    scopus 로고
    • In vivo migration and function of transferred HIV-1-speciflc cytotoxic T cells
    • Brodie SJ, Lewinsohn DA, Patterson BK, et al. In vivo migration and function of transferred HIV-1-speciflc cytotoxic T cells. Nat Med 1999, 5:34-41.
    • (1999) Nat Med , vol.5 , pp. 34-41
    • Brodie, S.J.1    Lewinsohn, D.A.2    Patterson, B.K.3
  • 36
    • 0022967777 scopus 로고
    • CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication
    • Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ Lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563-1566.
    • (1986) Science , vol.234 , pp. 1563-1566
    • Walker, C.M.1    Moody, D.J.2    Stites, D.P.3    Levy, J.A.4
  • 37
    • 0030009546 scopus 로고    scopus 로고
    • Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells
    • Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996, 17:217-224.
    • (1996) Immunol Today , vol.17 , pp. 217-224
    • Levy, J.A.1    Mackewicz, C.E.2    Barker, E.3
  • 38
    • 0029417004 scopus 로고
    • Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
    • Cocchi F, De Vico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
    • (1995) Science , vol.270 , pp. 1811-1815
    • Cocchi, F.1    De Vico, A.L.2    Garzino-Demo, A.3    Arya, S.K.4    Gallo, R.C.5    Lusso, P.6
  • 39
    • 0031757825 scopus 로고    scopus 로고
    • Role of interleukin-7 in T-cell development from hematopoietic stem cells
    • Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev 1998, 165:13-28.
    • (1998) Immunol Rev , vol.165 , pp. 13-28
    • Akashi, K.1    Kondo, M.2    Weissman, I.L.3
  • 40
    • 0031656033 scopus 로고    scopus 로고
    • IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells
    • Hassan J, Reen DJ. IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur J Immunol 1998, 28:3057-3065.
    • (1998) Eur J Immunol , vol.28 , pp. 3057-3065
    • Hassan, J.1    Reen, D.J.2
  • 41
    • 0003267921 scopus 로고    scopus 로고
    • A potential role for IL-7 in homeostasis in HIV infected patients
    • San Francisco, CA (USA), 30 January-2 February [Abstract LB1]
    • Fry TJ, Connick E, Landay A, et al. A potential role for IL-7 in homeostasis in HIV infected patients. In: 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA (USA), 30 January-2 February 2000 [Abstract LB1].
    • (2000) 7th Conference on Retroviruses and Opportunistic Infections
    • Fry, T.J.1    Connick, E.2    Landay, A.3
  • 42
    • 0034548861 scopus 로고    scopus 로고
    • T lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV
    • Clerici M, Saresella M, Colombo F, et al. T Lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000, 96:3866-3871.
    • (2000) Blood , vol.96 , pp. 3866-3871
    • Clerici, M.1    Saresella, M.2    Colombo, F.3
  • 43
    • 0035138982 scopus 로고    scopus 로고
    • Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis
    • Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001, 7:73-79.
    • (2001) Nat Med , vol.7 , pp. 73-79
    • Napolitano, L.A.1    Grant, R.M.2    Deeks, S.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.